Searched for
NOVARTIS DEAL
Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...21 May, 2026, 12.28 PM IST- Novartis to acquire Avidity Biosciences for about $12 billionNovartis is acquiring U.S. biotech firm Avidity Biosciences for approximately $12 billion in cash to expand its rare disease treatment port...27 Oct, 2025, 06.26 AM IST
- Novartis signs up to $5.2 billion heart drugs licensing deal with China's ArgoNovartis has entered into a licensing and options agreement with Argo Biopharmaceutical, valued at up to $5.2 billion. The deal encompasses...03 Sep, 2025, 05.26 PM IST
- Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...01 Apr, 2025, 11.50 PM IST
- Novartis agrees to make ingredients Roche's Actemra for COVID-19 patientsThe arrangement is the third transaction signed by Novartis following agreements with BioNTech and CureVac to make therapies for other firm...15 Apr, 2021, 11.55 AM IST
- Novartis signs $50 million deal for Mesoblast cell therapy for COVID and beyondThe Swiss drugmaker's deal with Australia-based Mesoblast secures rights to develop, commercialize and manufacture Remestemcel-L for treati...20 Nov, 2020, 02.40 PM IST
- Torrent close to buying women healthcare portfolio of Swiss pharma major NovartisSources say cos have already signed a business transfer deal for the domestic women healthcare portfolio, which is worth around Rs 300 cror...08 Apr, 2017, 12.04 PM IST
- Lupin, Cipla, other top drugmakers in fray for Novartis’ brandsThe Novartis portfolio includes top-selling brand TOBI Podhaler, a drug prescribed for symptomatic relief to patients suffering from cystic...31 Mar, 2017, 01.06 AM IST
- Rs 2,000 crore Novartis deal to help Sun Pharma rise in JapanThe discussions between Sun Pharma and Novartis, according to people privy to the matter, pertain to hiving off a handful of older products.14 Nov, 2015, 07.30 AM IST
- Novartis buys another 2.5% in Israel's Gamida CellNovartis will not have rights or options to Gamida Cell products or technology under the terms of the agreement.11 Oct, 2015, 03.16 PM IST
- Competition Commission of India clears Novartis-GlaxoSmithKline pharma dealThe multi-layered deal involves UK-based GlaxoSmithKline acquiring Novartis's vaccine biz, while latter would purchase GSK's cancer drugs p...23 Dec, 2014, 08.48 PM IST
- Novartis India rallies over 2% on three way deal with GlaxoSmithKlineGSK will sell its portfolio of cancer drugs to Novartis for $14.5 billion, plus another $1.5 billion, depending on trials in progress, ET r...23 Apr, 2014, 04.54 PM IST
- Novartis revamps pharma world with mega-deals with GSK, Eli LillyThe Swiss drugmaker said it would divest its vaccines business, excluding flu, to GSK for $7.1 million plus royalties.22 Apr, 2014, 06.59 PM IST
- Novartis India surges 20% as parent company strikes $15 billion deal with GSK, LillyNovartis on Tuesday said it will buy GSK's oncology products business. Separately, Novartis said it will sell off its animal health divisio...22 Apr, 2014, 12.42 PM IST
- Novartis concludes acquisition of 77% Alcon stake from NestleNovartis on Thursday said it has concluded a $28.3 billion deal with Alcon Inc that will give the Swiss drug-maker a controlling stake in t...26 Aug, 2010, 09.54 PM IST
- Novartis buys part of generics maker for $1.2 bnSwiss pharmaceuticals giant Novartis AG will buy the generic injectable cancer drugs business of Austria's EBEWE Pharma for euro925 million...21 May, 2009, 04.15 AM IST
- Novartis buys stake in Nestle eyecare unit for $11 bnNestle based in Switzerland said it would use the funds from the divestment to support opportunities for growth. Go nutty for health | In P...07 Apr, 2008, 03.33 PM IST
Load More
